Searched for
DRUG RITUXIMAB
Dr Reddy's says Wegovy copycat to be priced competitively, with 50-60% discounts feasibleIndian drugmaker Dr Reddy's Laboratories is set to launch a generic version of the popular weight-loss drug Wegovy. The company aims to off...- Dr Reddy's application for biosimilar candidate accepted for review by USFDARituximab is used to treat certain autoimmune diseases and types of cancer. "This milestone underscores our capability for global clinical ...
- Can Covid vaccines work on compromised immune systems?Immunocompromised people aren't a uniform group, and so may respond to vaccines differently.
- Expect to launch 25 products in US this fiscal: Dr Reddy'sDr Reddy's Laboratories expects to launch 25 products in the US market in the current financial year, according to a top company official. ...
- Roche Pharma India expands partnership with Cipla for key oncology medicinesRoche Pharma India has signed a "distribution agreement with Cipla to expand the scope of the partnership to include, marketing and distrib...
- Roche, Emcure may end pact to make 2 blockbuster drugsEmcure is still the distributor for those two drugs in India. Roche had handed out the manufacturing and marketing of trastuzumab and ritux...
- Critical illness drugs remain unaffordableIn fact, prices of certain drugs like trastuzumab are negotiated by patients with distributors, and hence available at a 25-30% discount to...
- Biosimilar drugs are priced too high and do little to improve accessibility: DoctorsBiosimilar drugs are follow-on biologics that have nearly the same efficacy as the original drug and used to treat cancer or autoimmune dis...
- Reliance Lifesciences launches world's first biosimilar used to treat advanced cancersIn 2014, Reliance had entered into a similar arrangement with Torrent Pharma to sell copies of three drugs -- rituximab, adalimumab and cet...
- Hetero launches biosimilar Rituximab in IndiaHetero has launched biosimilar Rituximab in India used for treatment of certain types of cancers and rheumatoid arthritis under the brand n...
- Hetero launches biosimilar Rituximab in IndiaHyderabad based Hetero pharma has launched biosimilar drug Rituximab under the brand name of MABALL, used in the treatment of blood cancer.
- NPPA invites comments on Tata Memorial list of cancer drugs"(this is) on revision of NLEM 2011 with respect to addition/ deletion of drugs relating to oncology from price control and affordability a...
- Claris Lifesciences gets USFDA drug approvalClaris Lifesciences Ltd, a parenteral drug company has received drug approval from US drug authorities for hypertension and angina treatmen...
- Intas Pharmaceutical launches low cost drug 'Mabtas' for cancer treatmentIntas Pharmaceutical today said it has launched 'Mabtas' a new low cost drug for treating cancer in India.
- Swiss-based Roche to produce two cancer drugs locally with Emcure Pharma: GovtRoche has entered into an agreement for a transfer technology project with Emcure for local manufacturing of its two patented cancer drugs.
- Cancer drugs made by Emcure, Roche still expensive for patientsLast year, Swiss drug maker Roche, said it had signed a deal with Emcure Pharma to manufacture low-cost versions of its breast cancer drug.
- Natco Pharmaceuticals inks pact with Swiss firm Chemo Sa Lugano for purchase of drug ingredientsNatco Pharmaceuticals said it has entered into an agreement with Mabxience to purchase four ingredients that will be used in finished drugs.
- Cipla to partner Chinese co in selling Roche, Amgen drug clonesCipla, the Indian drugmaker that built a $1-billion business making generic HIV treatments, aims to sell copies of Roche Holding's and Amge...
- Dr Reddy's plans to file 20 new drug applicationsDr Reddy’s Laboratories is betting on the US market and plans to file about 20 more ANDAs (Abbreviated New Drug Applications) in 2008. Reso...
- Roche gets nod for Mabthera for arthritisRoche has received approval for its drug Mabthera (rituximab) in India for the treatment of rheumatoid arthritis.
Load More
